Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Glazer

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Current Medical Research and Opinion|February 13, 2009
Long-term tolerability and efficacy of the combination of amlodipine/valsartan in hypertensive patients: a 54-week, open-label extension studyThomas Philipp, Robert D Glazer, Yanxing Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1971
Genes for neuronal properties expressed in neuroblastoma x L cell hybridsJ Minna, P Nelson, J Peacock, et al.
Journal of the American Academy of Dermatology|April 1, 1982
A study of potential hepatotoxicity of etretinate used in the treatment of psoriasisS D Glazer, H H Roenigk, H Yokoo, et al.
Hypertension (Dallas, Tex. : 1979)|May 28, 2009
Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trialDavid A Calhoun, Yves Lacourcière, Yann Tong Chiang, et al.
Advances in Therapy|December 22, 2009
Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safetyDavid A Calhoun, Nora A Crikelair, Joseph Yen, et al.
Journal of Human Hypertension|January 21, 2011
24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertensionY Lacourcière, N Crikelair, R D Glazer, et al.
Journal of the American Academy of Dermatology|April 1, 1984
Ultrastructural survey and tissue analysis of human livers after a 6-month course of etretinateS D Glazer, H H Roenigk, H Yokoo, et al.
Current Medical Research and Opinion|June 1, 2013
Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertensionDavid A Calhoun, Yves Lacourcière, Nora Crikelair, et al.
Journal of Human Hypertension|February 26, 2010
Achieving blood pressure goal: initial therapy with valsartan/hydrochlorothiazide combination compared with monotherapyM H Weinberger, R D Glazer, N A Crikelair, et al.
Journal of Cardiac Failure|July 15, 1999
Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failureJ N Cohn, G Tognoni, R D Glazer, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Current Medical Research and Opinion|February 13, 2009
Long-term tolerability and efficacy of the combination of amlodipine/valsartan in hypertensive patients: a 54-week, open-label extension studyThomas Philipp, Robert D Glazer, Yanxing Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1971
Genes for neuronal properties expressed in neuroblastoma x L cell hybridsJ Minna, P Nelson, J Peacock, et al.
Journal of the American Academy of Dermatology|April 1, 1982
A study of potential hepatotoxicity of etretinate used in the treatment of psoriasisS D Glazer, H H Roenigk, H Yokoo, et al.
Hypertension (Dallas, Tex. : 1979)|May 28, 2009
Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trialDavid A Calhoun, Yves Lacourcière, Yann Tong Chiang, et al.
Advances in Therapy|December 22, 2009
Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safetyDavid A Calhoun, Nora A Crikelair, Joseph Yen, et al.
Journal of Human Hypertension|January 21, 2011
24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertensionY Lacourcière, N Crikelair, R D Glazer, et al.
Journal of the American Academy of Dermatology|April 1, 1984
Ultrastructural survey and tissue analysis of human livers after a 6-month course of etretinateS D Glazer, H H Roenigk, H Yokoo, et al.
Current Medical Research and Opinion|June 1, 2013
Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertensionDavid A Calhoun, Yves Lacourcière, Nora Crikelair, et al.
Journal of Human Hypertension|February 26, 2010
Achieving blood pressure goal: initial therapy with valsartan/hydrochlorothiazide combination compared with monotherapyM H Weinberger, R D Glazer, N A Crikelair, et al.
Journal of Cardiac Failure|July 15, 1999
Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failureJ N Cohn, G Tognoni, R D Glazer, et al.
Pageof 4